Kazumasa Akagi

Statistics

Publications

Citations

H-Index

Active since

2021

Affiliations

Nagasaki University(Current)

Japanese Red Cross Society, Japan

Kazumasa Akagi is an author at Nagasaki University specializing in tuberculosis diagnostic testing, pulmonary tuberculosis diagnosis, and pulmonary tuberculosis.

ORCID

Publications per year

2021–2022

Publications

First clinical evaluation of the QIAreach <sup>TM</sup> QuantiFERON-TB for tuberculosis infection and active pulmonary disease

Kiyoyasu Fukushima, Kazumasa Akagi, Akane Kondo et al. · Pulmonology · 2021 · 33 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Clinical evaluation of QuantiFERON®-TB Gold Plus directly compared with QuantiFERON®-TB Gold In-Tube and T-Spot®.TB for active pulmonary tuberculosis in the elderly

Kiyoyasu Fukushima, Toru Kubo, Kazumasa Akagi et al. · Journal of Infection and Chemotherapy · 2021 · 21 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +16

<scp>Pan‐HER</scp> inhibitors overcome lorlatinib resistance caused by <scp>NRG1</scp>/<scp>HER3</scp> activation in <scp><i>ALK</i></scp>‐rearranged lung cancer

Hirokazu Taniguchi, Kazumasa Akagi, Yosuke Dotsu et al. · Cancer Science · 2022 · 14 citations · Full text

Medicine, Oncology, Pharmacology +16

Early change in the clearance of pembrolizumab reflects the survival and therapeutic response: A population pharmacokinetic analysis in real-world non-small cell lung cancer patients

Mayu Ohuchi, Shigehiro Yagishita, Hitomi Jo et al. · Lung Cancer · 2022 · 12 citations

Pharmacy, Oncology, Pharmacokinetics +16

1–4 of 4